Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

News

      OncoImmune, Inc. Raises $56 Million Series B Financing for Novel Cancer and COVID-19 Therapeutics

      Drug Development
      OncoImmune, Inc. announced the completion of a $56 million financing in Series B equity co-led by HM Capital and a blue-chip investor. Existing investors,...

      Sharp launches Clinventory Inventory Management System (IMS) for clinical trials

      Clinical Trials
      Sharp – part of UDG Healthcare plc, a global leader in contract packaging clinical supply services, has launched a new Inventory Management System (IMS)...

      Blueprint and Roche Take on Lilly As FDA Approves RET-Targeting Lung Cancer Drug

      FDA Approvals
      Cancer drugs firm Blueprint Medicines has gained a second US approval, with its Gavreto (pralsetinib) daily pill that targets non-small cell lung cancer with...

      Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer

      FDA Approvals
      Roche announced U.S. FDA approval for the expanded use of CINtec® PLUS Cytology, the first triage test based on biomarker technology for women whose...

      Valneva Announces Major COVID-19 Vaccine Partnership with U.K. Government

      Europe
      Valneva SE, a specialty vaccine company focused on prevention against diseases with major unmet needs, announced a vaccine partnership with the UK government for...

      Merck and Seattle Genetics Ink Two New Strategic Cancer Collaborations

      Drug Development
      Merck is making a major investment into Bothwell, Washington-based Seattle Genetics with two strategic oncology deals. Seattle Genetics’ shares rocketed 12% in premarket trading...

      Gilead’s $21 Billion Purchase of Immunomedics Boosts ADC Field

      Drug Development
      In the largest deal in its 33-year history, Gilead Sciences has agreed to pay $21 billion to acquire Immunomedics and its recently-approved antibody-drug conjugate...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector .....Read More

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.